Please Wait
Applying Filters...
menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Dinutuximab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ligand to Acquire APEIRON Biologics AG for $100 Million
    Ligand to Acquire APEIRON Biologics AG for $100 Million

    08 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240706652097/en

    BUSINESSWIRE
    08 Jul 2024
    Share Share
    BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.
    BeiGene and EUSA Pharma announce China NMPA approval of QARZIBA.

    17 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210817005630/en

    BUSINESSWIRE
    17 Aug 2021
    Share Share
    EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA
    EUSA Pharma and BeiGene Announce Acceptance of a BLA for QARZIBA

    09 Nov 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201109005558/en

    BUSINESSWIRE
    09 Nov 2020
    Share Share
    United Therap's Biological Dinutuximab Receives Approval In US
    United Therap's Biological Dinutuximab Receives Approval In US

    29 Sep 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125516

    FDA
    29 Sep 2020
    Share Share
    United Therapeutics Announces Study of Unituxin® for Small Cell Lung Cancer
    United Therapeutics Announces Study of Unituxin® for Small Cell Lung Cancer

    03 Feb 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/united-therapeutics-announces-study-of-unituxin-dinutuximab-for-small-cell-lung-cancer-did-not-meet-primary-endpoint-300997373.html

    PR NEWSWIRE
    03 Feb 2020
    Share Share
    SMC endorses EUSA Pharma’s Qarziba
    SMC endorses EUSA Pharma’s Qarziba

    13 Nov 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/smc_endorses_eusa_pharmas_qarziba_1259986

    Selina McKee PHARMA TIMES
    13 Nov 2018
    Share Share